Pneumococcal Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-08-02
Clinical Trial Update: A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the polyvalent pneumococcal conjugate vaccine V116 in adults has completed with posted results.